Association of Neutralizing Antispike Monoclonal Antibody Treatment With Coronavirus Disease 2019 Hospitalization and Assessment of the Monoclonal Antibody Screening Score
Authors:
- Katie L. KunzeKKKatie L. Kunze
- Jonathon W. SenefeldJSJonathon W. Senefeld
- Jorge E. SinclairJSJorge E. Sinclair
- Shahin IshaSIShahin Isha
- Parthkumar H. SatashiaPSParthkumar H. Satashia
- Shivang BhaktaSBShivang Bhakta
- Jennifer B. CowartJCJennifer B. Cowart
- Wendelyn BoschWBWendelyn Bosch
- Jack O’hOroJOJack O’hOro
- Sadia Z. ShahSSSadia Z. Shah
Open Access
- 11 January 2023
- journal article
- research article
- Published by Elsevier in Mayo Clinic Proceedings: Innovations, Quality & Outcomes
- Vol. 7 (2) , 109-121
Abstract
No abstract availableKeywords
Funding Information
- National Heart, Lung, and Blood Institute (1F32HL154320)
- Mayo Clinic
- National Center for Advancing Translational Sciences (UL1TR002377)
This publication has 23 references indexed in Scilit:
- Bamlanivimab + etesevimab therapy induces SARS-CoV-2 immune escape mutations and secondary clinical deterioration in COVID-19 patients with B-cell malignanciesAnnals of Oncology, 2021
- SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectivenessThe Lancet, 2021
- A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to High-Risk Patients with Mild-to-Moderate Coronavirus Disease-19Mayo Clinic Proceedings, 2021
- Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19JAMA, 2021
- Phylogenetic analysis of SARS-CoV-2 in Boston highlights the impact of superspreading eventsScience, 2021
- REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19New England Journal of Medicine, 2021
- SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19New England Journal of Medicine, 2021
- Influence of Social and Cultural Factors on the Decision to Consent for Monoclonal Antibody Treatment among High-Risk Patients with Mild-Moderate COVID-19Journal of Primary Care & Community Health, 2021
- Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity‐score matched samplesStatistics in Medicine, 2009
- Nomogram for number needed to treat will be of limited useBMJ, 1996